Risk factors for testicular cancer - differences between pure non-seminoma and mixed seminoma/non-seminoma?

被引:28
|
作者
Aschim, E. L.
Haugen, T. B.
Tretli, S.
Daltveit, A. K.
Grotmol, T.
机构
[1] Oslo Univ Coll, Fac Hlth Sci, N-0130 Oslo, Norway
[2] Univ Hosp, Rikshosp, Dept Obstet & Gynaecol, Androl Lab, Oslo, Norway
[3] Canc Registry Norway, Oslo, Norway
[4] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, Bergen, Norway
[5] Med Birth Registry Norway, Bergen, Norway
来源
INTERNATIONAL JOURNAL OF ANDROLOGY | 2006年 / 29卷 / 04期
关键词
histology; placenta; risk factors; testicular cancer;
D O I
10.1111/j.1365-2605.2005.00632.x
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The origin of testicular germ cell cancer (TGCC) is believed to be carcinoma in situ cells developed in utero. Clinically, TGCCs are divided into two major histological groups, seminomas and non-seminomas, where the latter group includes non-seminomatous TGCCs with seminomatous components (mixed S/NS TGCC). Recent studies, however, have suggested that non-seminomas and mixed S/NS TGCCs could have certain differences in aetiology, and in this study the TGCCs were divided into three, rather than the conventional two histological groups. A large case-control study was undertaken on data on all live-born boys registered in the Medical Birth Registry of Norway during the period 1967-1998 (n = 961 396). Among these were 1087 TGCC cases registered in the Cancer Registry of Norway until February 2004. We found several risk factors for TGCC, including low parity, low gestational age, epilepsy and retained placenta. Several of the variables studied seemed to be risk factors for specific histological groups, e.g. parity 0 vs. 2 and low gestational age being associated with increased risk of non-seminomas, but not of mixed S/NS TGCC, and low maternal age being associated with increased risk of mixed S/NS TGCC, but not of non-seminomatous TGCC. Therefore, our results might suggest that non-seminomas and mixed S/NS TGCCs have partially different risk factors, whose associations may be obscured by combining these two histological groups. The histological groups were not significantly different, however. Most of our findings on risk factors for TGCC are in agreement with at least some previous studies. An unexplainable exception is low birth weight being associated with reduced risk of TGCC in our study.
引用
收藏
页码:458 / 467
页数:10
相关论文
共 50 条
  • [41] LYMPHOGRAPHY IN RETROPERITONEAL METASTASES IN NON-SEMINOMA TESTICULAR-TUMOR PATIENTS WITH A NORMAL CT SCAN
    LIEN, HH
    FOSSA, SD
    OUS, S
    STENWIG, AE
    ACTA RADIOLOGICA-DIAGNOSIS, 1983, 24 (04): : 319 - 322
  • [42] Editorial Comment: New Insights on the Mechanisms Affecting Fertility in Men with Non-Seminoma Testicular Cancer before Cancer Therapy
    Guimaraes, Gustavo Cardoso
    INTERNATIONAL BRAZ J UROL, 2020, 46 (02): : 277 - 278
  • [43] Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal Cancer
    Nolting, Julia
    Draeger, Desiree Louise
    Hakenberg, Oliver W.
    Schneidewind, Laila
    UROLOGIA INTERNATIONALIS, 2023, 107 (04) : 429 - 431
  • [44] Intra-cardiac metastasis from testicular non-seminoma germ cell tumour; to resect or not to resect
    Taghavi, Fouad
    Markar, Sheraz
    Williams, Michael
    Large, Stephen
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2010, 11 (06) : 843 - 845
  • [45] COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA
    STOTER, G
    VENDRIK, CPJ
    STRUYVENBERG, A
    BROUWERS, TM
    SLEIJFER, DT
    KOOPS, HS
    VANOOSTEROM, AT
    PINEDO, HM
    LANCET, 1979, 1 (8123): : 941 - 945
  • [46] CXCL12 IS A PREDICTOR FOR DISEASE RECURRENCE IN PATIENTS WITH METASTATIC NON-SEMINOMA
    Fankhauser, Christian
    Roth, Lisa
    Beyer, Joerg
    Sulser, Tullio
    Moch, Holger
    Hermanns, Thomas
    Bode, Peter-Karl
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1087 - E1087
  • [47] Appendix 9: Testicular seminoma and non-seminoma: eUpdate published online 29 June 2017 (www.esmo.org/Guidelines/Genitourinary-Cancers)
    Oldenburg, J.
    Horwich, A.
    ANNALS OF ONCOLOGY, 2017, 28 : 165 - 166
  • [48] INCREMENTAL DOSE-RESPONSE EFFECT OF AGE ON MORTALITY IN NON-SEMINOMA TESTIS CANCER PATIENTS
    Incesu, Reha-Baris
    Piccinelli, Mattia Luca
    Morra, Simone
    Scheipner, Lukas
    Tappero, Stefano
    Barletta, Francesco
    Garcia, Cristina Cano
    Tian, Zhe
    Saad, Fred
    Shariat, Shahrokh F.
    Chun, Felix K. H.
    Briganti, Alberto
    Terrone, Carlo
    Ahyai, Sascha
    Longo, Nicola
    de Cobelli, Ottavio
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1 - E1
  • [49] Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study
    Wagner, Thomas
    Toft, Birgitte Gronkaer
    Lauritsen, Jakob
    Bandak, Mikkel
    Christensen, Ib Jarle
    Engvad, Birte
    Kreiberg, Michael
    Agerbaek, Mads
    Dysager, Lars
    Carus, Andreas
    Rosenvilde, Josephine Julie
    Berney, Daniel
    Daugaard, Gedske
    EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [50] RLA successful with patients with non-seminoma in clinical stage O with or without vascular invasion
    Brudermanns, Britta
    AKTUELLE UROLOGIE, 2007, 38 (01) : 1 - 1